Connect with us

Company News

InspireMD names Andrea Tommasoli as COO

InspireMD, Inc., developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that it has promoted Andrea Tommasoli to Chief Operating Officer. Tommasoli formerly served as the Company’s Senior Vice President of Global Sales & Marketing since joining InspireMD in November 2020.

“Andrea has been instrumental in expanding the footprint of CGuard EPS across our approved markets in the EU and, as we advance toward potential U.S. approval with our ongoing U.S. Investigational Device Exemption (IDE) clinical trial, and as our business requirements shift toward operational capacity to support our commercial growth, we believe his background and skill set make him an ideal candidate to assume the role of Chief Operating Officer of the Company at this important time.” Stated Marvin Slosman, Chief Executive Officer of InspireMD. “On behalf of the entire InspireMD team, I would like to congratulate Andrea on this promotion and look forward to his continued contributions.”

“I joined InspireMD because of the tremendous potential of the CGuard EPS stent platform in changing the standard of care for Carotid revascularization through our proprietary MicroNet™ technology,” stated Tommasoli. “As the needs of the business grow beyond European commercialization, I am pleased to be able to play a more significant leadership role with broader responsibilities to drive scalability and operational efficiency to meet our anticipated growth needs. I am highly confident in the Company’s ability to meet these ever-expanding drivers of growth and look forward to serving in this important role.”

Tommasoli joined InspireMD from Integra LifeSciences, where he served in several senior commercial leadership roles, most recently as Senior Sales Director – Indirect Markets, where he led the commercial expansion and integration of Codman’s acquired portfolio in all OUS indirect countries. Before that, Tommasoli ran Integra’s Neurosurgery and Instruments business in direct sales countries in Europe. Prior to Integra, Tommasoli was the Director of St. Jude Medical’s Neuromodulation division in France. Tommasoli received his B.A. in nuclear engineering from Bologna University, Italy and his M.B.A. from HEC Paris, France.
MB Bureau

Copyright © 2024 Medical Buyer

error: Content is protected !!